These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10553047)

  • 21. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-12 receptor (IL-12R) expression and accumulation of IL-12R beta 1 and IL-12R beta 2 mRNAs in CD4+ T cells by costimulation with B7-2 molecules.
    Igarashi O; Yamane H; Imajoh-Ohmi S; Nariuchi H
    J Immunol; 1998 Feb; 160(4):1638-46. PubMed ID: 9469420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma.
    Hoshino T; Winkler-Pickett RT; Mason AT; Ortaldo JR; Young HA
    J Immunol; 1999 Jan; 162(1):51-9. PubMed ID: 9886369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells.
    Tenger C; Sundborger A; Jawien J; Zhou X
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):791-6. PubMed ID: 15604417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
    Agrewala JN; Suvas S; Verma RK; Mishra GC
    J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
    Fogler WE; Volker K; Watanabe M; Wigginton JM; Roessler P; Brunda MJ; Ortaldo JR; Wiltrout RH
    J Immunol; 1998 Dec; 161(11):6014-21. PubMed ID: 9834083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness.
    Wu CY; Wang K; McDyer JF; Seder RA
    J Immunol; 1998 Sep; 161(6):2723-30. PubMed ID: 9743329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
    Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
    J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
    Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
    Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.
    Gillessen S; Carvajal D; Ling P; Podlaski FJ; Stremlo DL; Familletti PC; Gubler U; Presky DH; Stern AS; Gately MK
    Eur J Immunol; 1995 Jan; 25(1):200-6. PubMed ID: 7843232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM; Ju ST; Lu CY; Sy MS
    J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological function and distribution of human interleukin-12 receptor beta chain.
    Wu CY; Warrier RR; Carvajal DM; Chua AO; Minetti LJ; Chizzonite R; Mongini PK; Stern AS; Gubler U; Presky DH; Gately MK
    Eur J Immunol; 1996 Feb; 26(2):345-50. PubMed ID: 8617302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanisms.
    Hunter SE; Waldburger KE; Thibodeaux DK; Schaub RG; Goldman SJ; Leonard JP
    Eur J Immunol; 1997 Dec; 27(12):3438-46. PubMed ID: 9464833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.